Biotechnology Stocks I Performance Guide: Vertex Pharmaceuticals Incorporated (VRTX)
VRTX has no dividends
Table and Chart of VRTX Performance
See what a $1,000 investment in VRTX is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| VRTX Returns | |
|---|---|
| Start Date | Dec-31-2013 |
| Start Price | $74.30 |
| End Date | Dec-01-2023 |
| End Price | $351.16 |
| # Prices | 121 |
| Min Date | Apr-30-2014 |
| Min Price | $67.70 |
| Max Date | Oct-31-2023 |
| Max Price | $362.11 |
| Total Return | 372.62% |
| Annualized Return | 16.65% |
| Current Value of $1,000 Purchase | $4,726 |
| Number Returns | 7,260 |
| Average Return | 80.26% |
| Number Profitable Returns | 6,460 |
| Percent Profitable Returns | 88.98% |
| Number Unprofitable Returns | 800 |
| Percent Unprofitable Returns | 11.02% |
| Profitable to Unprofitable Returns Ratio | 8.08 |
| VRTX Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $90,487,964,000 | Price to Sales | 9.37 |
| Earnings per Share | $13.3100 |
| PE Ratio | 26.38 |
| PE to Growth Ratio | 0.496 |
| Price to Book | 5.48 |
| PRICE DATA | |
| 52 Week High | $387.42 |
| 52 Week Low | $282.21 |
| Analyst Target Price | $400 |
| 50-Day Moving Average | $360.61 |
| 200-Day Moving Average | $340.27 |
| FINANCIAL DATA | |
| Revenue per Share | $37.49 |
| Revenue | $9,654,200,000 |
| Profit Margin | 35.9% |
| Return on Equity | 0.235% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
VRTX Compare Returns with S&P 500
VRTX Trendline Chart